Live from the NIH registry
Studies recruiting near Alexandria right now
Top 25 of 2,303 recruiting studies, sorted by proximity — each links to its official registry page
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Georgetown University - Lombardi CCC — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Georgetown University Medical Center — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Using Aspirin to Improve Immunological Features of Ovarian Tumors
Ovarian Cancer, Fallopian Tube Cancer
EARLY/Phase 1
Interventional 100 participants sought
Inova Schar Cancer Institute — Fairfax, Virginia (12.0 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma
Phase 1
Interventional 25 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Group of Washington — Chevy Chase, Maryland (12.8 mi)
· Sponsor: Genentech, Inc.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Follicular Lymphoma, Lymphoma
Phase 2
Interventional 152 participants sought
Georgetown University (Data Collection Only) — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
NEXT Oncology Virginia — Fairfax, Virginia (12.0 mi)
· Sponsor: Astellas Pharma Inc
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Children's National Medical Center — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Nationwide Children's Hospital
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Human Papilloma Virus, Anal Dysplasia
Phase 2
Interventional 120 participants sought
RIIS Clinic at HIPS — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: University of Maryland, Baltimore
The Pathogenesis and Natural History of Sjogren's Disease
Sjogren's Syndrome, Salivary Gland
N/A
Observational 300 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi)
· Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Study of Alkaptonuria
Alkaptonuria
N/A
Observational 300 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi)
· Sponsor: National Human Genome Research Institute (NHGRI)
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
Georgetown University — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Diagnosis and Treatment of Leishmania Infections
Leishmaniasis, Skin Diseases, Parasitic
N/A
Observational 289 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
RESET System Pivotal Trial (Rev F)
Diabetes type2, Obesity
N/A
Interventional 264 participants sought
MedStar Health Research Institute — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Morphic Medical Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi)
· Sponsor: Nurix Therapeutics, Inc.
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
Rotator Cuff Tears, Rotator Cuff Injuries
Phase 4
Interventional 100 participants sought
Walter Reed National Military Medical Center — Bethesda, Maryland (11.2 mi)
· Sponsor: Brooke Army Medical Center
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Medstar Washington Hospital Center — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Cook Research Incorporated
Sensory Feedback and Hand Motor Adaptation
Stroke
EARLY/Phase 1
Interventional 30 participants sought
Catholic University of America — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: The Catholic University of America
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Phase 1
Interventional 50 participants sought
Childrens National Medical Center — Washington D.C., District of Columbia (5.9 mi)
· Sponsor: Catherine Bollard
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
Inova Fairfax Hospital — Falls Church, Virginia (6.4 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
MD Medical Research - Oxon Hill — Oxon Hill, Maryland (5.3 mi)
· Sponsor: Crystalys Therapeutics
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Cancer, Tumor, Solid
Phase 1, Phase 2
Interventional 168 participants sought
NEXT Virginia — Fairfax, Virginia (12.0 mi)
· Sponsor: OncoResponse, Inc.
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Vienna, Virginia (11.2 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
The Retina Group of Washington — Fairfax, Virginia (12.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.